NIH, Wellcome Trust award millions to cultivate African genomic research
This article was originally published in Scrip
In an effort to ensure scientists in Africa – the "original cradle of all humanity," according to National Institutes of Health (NIH) Director Dr Francis Collins – are able to take advantage of and effectively capitalize on the worldwide genomics revolution, the US government and the London-based global charity Wellcome Trust on 8 October awarded millions of dollars in the first series of grants aimed at spurring genomic research in kidney disease, diabetes, heart disease, obesity, tuberculosis and African sleeping sickness.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.